IDEAYA Biosciences (IDYA) Assets Average (2019 - 2026)

IDEAYA Biosciences has disclosed Assets Average across 8 years of filings, most recently posting $1.1 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $1.1 billion, down 3.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 3.82% YoY), and the FY2025 annual result was $1.1 billion, up 25.94% from the prior year.
• Assets Average came in at $1.1 billion for Q1 2026 at IDEAYA Biosciences, down from $1.1 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.2 billion in Q4 2024 to a low of $348.4 million in Q2 2022.
• The 5-year median for Assets Average is $805.4 million (2024), against an average of $765.4 million.
• Across the five-year window, Assets Average soared 116.88% in 2024 and decreased 3.82% in 2026, its largest moves.
• IDEAYA Biosciences' Assets Average stood at $399.4 million in 2022, then surged by 47.99% to $591.1 million in 2023, then surged by 99.95% to $1.2 billion in 2024, then fell by 2.94% to $1.1 billion in 2025, then dropped by 6.75% to $1.1 billion in 2026.
• The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.